Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 26

Sort by

Sort Order Select

Journal Articles

ADAMTS13 Regulates Neutrophil Recruitment in a Mouse Model of Invasive Pulmonary Aspergillosis

Markus Radsak, MD, Steve Prüfer, PhD, Katharina Ebner, Michael Weber, PhD, Sebastian Reuter, PhD, Pamela Stein, PhD, Inge Scharrer, MD, Michael Stassen, PhD, Hansjörg Schild, PhD, Kerstin Jurk, PhD, Markus Bosmann, MD

Blood (2014) 124 (21): 4109.

https://doi.org/10.1182/blood.V124.21.4109.4109

Published: 2014

Journal Articles

Final Evaluation Of a Prospective, Non-Interventional Study On Efficacy and Tolerability Of a New Generation VWF/FVIII Concentrate In The Treatment Of Von Willebrand Disease

Sonja Alesci, MD, Mario Von Depka, Jennifer Feddern, Susan Halimeh, MD, Oliver Hegener, PhD, Janos Kadar, Wolfgang A. Miesbach, MD, PhD, Ulrike Nowak-Göttl, Inge Scharrer, MD, PhD

Blood (2013) 122 (21): 4775.

https://doi.org/10.1182/blood.V122.21.4775.4775

Published: 2013

Journal Articles

Descriptive Evaluation of Age-Related Differences in Clinical Manifestation and Treatment of Von Willebrand's Disease in an Open-Label, Prospective, Non-Interventional Study (wilate ® -SET)

Oliver Hegener, PhD, Inge Scharrer, MD, PhD, Jennifer Feddern, Wolfgang A. Miesbach V, MD, PhD, Mario Von Depka, Janos Kadar

Blood (2012) 120 (21): 4630.

https://doi.org/10.1182/blood.V120.21.4630.4630

Published: 2012

Journal Articles

An Evaluation of Fibrin(ogen) Determinants of Thromboelastography

Dennis K. Galanakis, MD, Miriam Rafailovich, Ph D, Tahmeena Ahmed, MD, Suphanne Pongkitwitoon, MS, Inge Scharrer, MD, PhD, Bohdan Kudryk, Ph D

Blood (2011) 118 (21): 2251.

https://doi.org/10.1182/blood.V118.21.2251.2251

Published: 2011

Journal Articles

ADAMTS13 In 4 Different VWF/VIII Concentrates and Its Impact on Therapy.

Mirjeta Qorraj, Tanja Falter, Sarah Steinemann, Thomas Vigh, Inge Scharrer, MD, PhD

Blood (2010) 116 (21): 3677.

https://doi.org/10.1182/blood.V116.21.3677.3677

Published: 2010

Journal Articles

Evaluation of Clotting Factor Concentrates for Treatment of Thrombotic Thrombocytopenic Purpura.

Tanja Falter, Mirjeta Qorraj, Sarah Steinemann, Thomas Vigh, Inge Scharrer, MD, PhD

Blood (2010) 116 (21): 3678.

https://doi.org/10.1182/blood.V116.21.3678.3678

Published: 2010

Journal Articles

Investigation of Side Effects of Plasmaexchange In the Treatment of Thrombotic Thrombocytopenic Purpura

Sarah Steinemann, Tanja Falter, Mirjeta Qorraj, Thomas Vigh, Inge Scharrer, MD, PhD

Blood (2010) 116 (21): 4661.

https://doi.org/10.1182/blood.V116.21.4661.4661

Published: 2010

Journal Articles

Five Novel Mutations in F13B Gene Resulting in FXIII Deficiency.

Vytautas Ivaskevicius, MD, Hannelore Rott, MD, Inge Scharrer, MD, PhD, Manuela Krause, MD, Erhard Seifried, MD, PhD, Johannes Oldenburg, MD, PhD

Blood (2007) 110 (11): 2150.

https://doi.org/10.1182/blood.V110.11.2150.2150

Published: 2007

Journal Articles

Response to Anti CD20 Monoclonal Antibody Rituximab® and Epitope Mapping of Inhibitory Antibodies in Patients with Acquired Haemophilia.

Manuela Krause, MD, Christoph Koenigs, MD, Christoph Kessel, Inge Scharrer, MD, Ralf Grossmann, MD, Wolfhard Kreuz, MD

Blood (2006) 108 (11): 1044.

https://doi.org/10.1182/blood.V108.11.1044.1044

Published: 2006

Journal Articles

Hepatocellular Carcinoma in Patients with Hemophilia and Chronic Hepatitis C Infection.

Charis von Auer, MD, Sandra Heinsdorf, Manuela Krause, MD, Wolfgang Miesbach, MD, Inge Scharrer, MD

Blood (2006) 108 (11): 4056.

https://doi.org/10.1182/blood.V108.11.4056.4056

Published: 2006

Journal Articles

Efficacy of Peri- and Postoperative Treatment in 95 Patients with Von Willebrand’s Disease.

Charis von Auer, MD, Kathrin Lotter, Sandra Heinsdorf, Inge Scharrer, MD

Blood (2006) 108 (11): 4075.

https://doi.org/10.1182/blood.V108.11.4075.4075

Published: 2006

Journal Articles

Congenital Dysfibrinogenemia - Clinical Manifestations in Relation to the Fibrinogen Gene Mutation.

Wolfgang A. Miesbach, MD, D. K. Galanakis, MD, Inge Scharrer, MD

Blood (2005) 106 (11): 2138.

https://doi.org/10.1182/blood.V106.11.2138.2138

Published: 2005

Journal Articles

ADAMTS-13 Activity and Antigen in Commercial Von Willebrand Factor Concentrates.

Inge Scharrer, MD, Martina Böhm, PhD

Blood (2005) 106 (11): 4027.

https://doi.org/10.1182/blood.V106.11.4027.4027

Published: 2005

Journal Articles

Evaluation of Thrombotic Events in Haemophiliacs Undergoing Major Orthopaedic Surgery without Thrombosis Prophylaxis.

Manuela Krause, MD, Charis von Auer, MD, Andreas Kurth, MD, Martina Boehm, MD, L. Hovy, MD, Inge Scharrer, MD

Blood (2005) 106 (11): 4072.

https://doi.org/10.1182/blood.V106.11.4072.4072

Published: 2005

Journal Articles

Lipoprotein (A) and Further Prothrombotic Risk Factors in Women with Unexplained Recurrent Miscarriage- Results of a Multicenter Case-Control Study.

Ulrike Nowak-Gottl, MD, Barbara Sonntag, MD, Robert Klamroth, MD, Achim Heinecke, MD, Claus Langer, PhD, Inge Scharrer, MD, Robert Greb, MD, Manuela Krause, MD

Blood (2004) 104 (11): 2599.

https://doi.org/10.1182/blood.V104.11.2599.2599

Published: 2004

Journal Articles

Monitoring of FVIII Replacement Therapy with Cell-Based Monitoring Tests.

Steffen Bassus, MD, PhD, Wolfgang Wegert, MS, Manuela Krause, MD, Inge Scharrer, MD, Thomas Scholz, Eng., Carmen Escuriola-Ettinghausen, MD, Annelie Siegemund, MD, Wolfhart Kreuz, MD, Lothar Engelmann, MD, Carl M. Kirchmaier, MD

Blood (2004) 104 (11): 3098.

https://doi.org/10.1182/blood.V104.11.3098.3098

Published: 2004

Journal Articles

Mutations in the VKORC1 Gene Cause Warfarin Resistance, Warfarin Sensitivity and Combined Deficiency of Vitamin K Dependent Coagulation Factors.

Johannes Oldenburg, MD, PhD, Simone Rost, Andreas Fregin, PhD, Christof Geisen, Vytautas Ivaskevicius, MD, Erhard Seifried, MD, Inge Scharrer, MD, Maximilian Heistinger, MD, Edward Tuddenham, MD, Clemens Muller-Reible, PhD, Barbara Zieger, MD

Blood (2004) 104 (11): 277.

https://doi.org/10.1182/blood.V104.11.277.277

Published: 2004

Journal Articles

Acquired Hemophilia Caused by Non-Hemophilic Factor VIII Gene Variants.

Andreas Tiede, MD, PhD, Roswith Eisert, MD, Andreas Czwalinna, PhD, Wolfgang Miesbach, MD, Inge Scharrer, MD, Arnold Ganser, MD, Mario von Depka, MD

Blood (2004) 104 (11): 3083.

https://doi.org/10.1182/blood.V104.11.3083.3083

Published: 2004

Journal Articles

The Predictive Value of hs-C-Reactive Protein Is Based on the Presence of Antiphospholipid Antibodies.

Wolfgang A. Miesbach, MD, Martina Boehm, PhD, Detlef Claus, MD, Inge Scharrer, MD

Blood (2004) 104 (11): 1046.

https://doi.org/10.1182/blood.V104.11.1046.1046

Published: 2004

Journal Articles

Relevance of Thrombophilic Risk Factors on Clinical Phenotype in Patients with Haemophilia A.

Manuela Krause, MD, Anika Hahn, Ferrial Peyvandi, MD, Inge Scharrer, MD

Blood (2004) 104 (11): 3981.

https://doi.org/10.1182/blood.V104.11.3981.3981

Published: 2004

NARROW

ADAMTS13 Regulates Neutrophil Recruitment in a Mouse Model of Invasive Pulmonary Aspergillosis

Final Evaluation Of a Prospective, Non-Interventional Study On Efficacy and Tolerability Of a New Generation VWF/FVIII Concentrate In The Treatment Of Von Willebrand Disease

Descriptive Evaluation of Age-Related Differences in Clinical Manifestation and Treatment of Von Willebrand's Disease in an Open-Label, Prospective, Non-Interventional Study (wilate ® -SET)

An Evaluation of Fibrin(ogen) Determinants of Thromboelastography

ADAMTS13 In 4 Different VWF/VIII Concentrates and Its Impact on Therapy.

Evaluation of Clotting Factor Concentrates for Treatment of Thrombotic Thrombocytopenic Purpura.

Investigation of Side Effects of Plasmaexchange In the Treatment of Thrombotic Thrombocytopenic Purpura

Five Novel Mutations in F13B Gene Resulting in FXIII Deficiency.

Response to Anti CD20 Monoclonal Antibody Rituximab® and Epitope Mapping of Inhibitory Antibodies in Patients with Acquired Haemophilia.

Hepatocellular Carcinoma in Patients with Hemophilia and Chronic Hepatitis C Infection.

Efficacy of Peri- and Postoperative Treatment in 95 Patients with Von Willebrand’s Disease.

Congenital Dysfibrinogenemia - Clinical Manifestations in Relation to the Fibrinogen Gene Mutation.

ADAMTS-13 Activity and Antigen in Commercial Von Willebrand Factor Concentrates.

Evaluation of Thrombotic Events in Haemophiliacs Undergoing Major Orthopaedic Surgery without Thrombosis Prophylaxis.

Lipoprotein (A) and Further Prothrombotic Risk Factors in Women with Unexplained Recurrent Miscarriage- Results of a Multicenter Case-Control Study.

Monitoring of FVIII Replacement Therapy with Cell-Based Monitoring Tests.

Mutations in the VKORC1 Gene Cause Warfarin Resistance, Warfarin Sensitivity and Combined Deficiency of Vitamin K Dependent Coagulation Factors.

Acquired Hemophilia Caused by Non-Hemophilic Factor VIII Gene Variants.

The Predictive Value of hs-C-Reactive Protein Is Based on the Presence of Antiphospholipid Antibodies.

Relevance of Thrombophilic Risk Factors on Clinical Phenotype in Patients with Haemophilia A.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only